By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pall Life Sciences 

600 South Wagner Road

Ann Arbor  Michigan  48103-9019  U.S.A.
Phone: 734-665-0651 Fax: 734-913-6114

Pall Life Sciences develops, manufactures, sells and services products to customers that conduct research in the life sciences field, or produce therapeutic biologicals, drugs, vaccines and other products in the biopharmaceuticals, in vitro diagnostic and healthcare markets.

Pall technology is used from the earliest stages of new drug discovery and development on through pilot and full-scale production and then delivery of therapies for the prevention, diagnosis and treatment of disease. Pall products help innovative drugs move faster to market and are used in laboratories, biotech applications, vaccine development, bioprocessing, fermentation, downstream processing, aseptic processing and sterile filling.

Pall maintains certified ISO9001 manufacturing facilities worldwide. The company’s Scientific and Laboratory Services (SLS), Technical Services and its Validation Laboratories have been a cornerstone of customer support for more than 30 years.

Biopharmaceuticals Market

Pall provides engineered filtration and purification technology products and systems in single-use and cleanable formats to support development and commercialization of drugs and vaccines. The increasing adoption of single-use processing systems to produce drugs and vaccines are an alternative to stainless steel, providing the industry with significant advantages – more flexible use of space and speed when implementing a new production line; reduction or elimination of hazardous cleaning chemicals and requisite cleaning validation, reduction of water consumption and energy demand, and reduction of the risk of cross-contamination between batches and products.

Pall’s biopharmaceuticals group addresses five sub-market segments – the biotechnology, vaccines and plasma sub-markets are biologically derived, while the active pharmaceutical ingredients (API) sub-market comprises chemically synthesized drugs and the formulation/filling sub-market applies to both synthetic and biologically-derived drugs. For each sub-market, Pall provides a broad range of advanced filtration and separation solutions for each critical stage of drug development through drug production. Filtration systems and validation services assist drug manufacturers through the regulatory process and onto the market.

For further information, please visit:

Key Statistics

Ownership: Private

Web Site: Pall Life Sciences
Symbol: PLL


Company News
Pall Life Sciences (PLL) Launches Kleenpak Presto Sterile Connectors For Genderless Fluid Transfer Applications 10/14/2016 11:43:38 AM
Pall Life Sciences (PLL) Extends The Range Of Continuous, Single-Use Technologies To Improve Speed And Quality Of Biopharmaceutical Production 10/4/2016 10:32:48 AM
Pall Life Sciences (PLL) To Introduce Continuous Bioprocessing With Single-Use Technologies 9/29/2016 10:30:24 AM
Ovizio Partners With Pall Life Sciences (PLL) To Expand And Commercialize The iLine S Microscope Range 10/29/2015 11:23:12 AM
Introducing the New Cadence™ Single-Use TFF Modules From Pall Life Sciences (PLL) 10/15/2013 10:12:38 AM
Pall Life Sciences (PLL) Showcases Innovative Syringe Filter at Pittcon Conference 3/5/2012 7:33:10 AM
Pall Life Sciences (PLL) Showcases New Sample Prep Products at Pittcon Conference 3/7/2011 5:19:37 PM
Connecticut Nursing Program Graduates Record Number 7/6/2009 3:32:53 PM
Pall Life Sciences (PLL) Receives Supplier of the Year Award From VWR Europe 7/6/2009 12:51:25 PM
Pall Life Sciences (PLL) Introduces Worldwide Advertising And Marketing Campaign 1/29/2009 3:15:04 PM